Core Insights - The event held at Shijiazhuang Edison Oncology Hospital from April 13 to 15, 2025, aimed to integrate international medical concepts with local healthcare needs, featuring representatives from Mayo Clinic, Meizhong Jiahe Medical Technology Development Group, and Shijiazhuang Edison Oncology Hospital [1][2][3][4] - The collaboration is expected to enhance the hospital's development in oncology care by adopting advanced international medical practices and management strategies [1][2][3] Group 1: International Collaboration - Mayo Clinic's team, led by Dr. Brian Costello, emphasized the importance of international medical cooperation in addressing cancer challenges and expressed hopes for a close partnership to improve cancer care globally [2][3] - Meizhong Jiahe has been collaborating with Mayo Clinic since 2020, implementing advanced management models and treatment techniques in its Guangzhou Taihe Oncology Hospital, which received positive feedback from the industry and patients [3] - The partnership aims to enhance the influence of Meizhong Jiahe in the international oncology market by aligning with Mayo Clinic's expertise in oncology [3] Group 2: Local Healthcare Development - Shijiazhuang Edison Oncology Hospital's General Manager, Pang Shizhen, highlighted the visit as a significant opportunity to adopt international healthcare models, potentially leading to transformative growth in oncology services [1] - Stone Pharmaceutical Group's Executive President, Zhen Hong, noted the alignment of both organizations' missions to improve global health, focusing on areas like new drug development and clinical trials [4] - Discussions during the event covered various topics, including patient needs, service capabilities, and best practices in clinical staffing, aiming to establish a solid foundation for future collaborations [4]
跨国携手谋新篇 妙佑医疗国际同美中嘉和、石药集团共谋国际化合作